ArticleCurrent microbiology2026
Biocosmetic Potential of Xylaria psidii, an Endophyte of Aegle marmelos.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, there is an impetus for natural and safe cosmetics, with cosmeceutical companies mainly seeking ingredients that offer minimal side effects. Biocosmetics are derived from plants, animals, microorganisms (bacteria/fungi), which are generally considered safer than synthetic chemical entities. Skin-lightening or hyperpigmentation-reducing agents are in great demand, which is largely based on the inhibition of tyrosinase, an enzyme essential for melanin biosynthesis. Fungi, in particular, are a rich source of bioactive compounds used in pharmaceuticals and cosmeceuticals. To the best of our knowledge, this is the first report evaluating the tyrosinase inhibitory and antioxidant properties of endophytic fungi isolated from Aegle marmelos (L.) Corrêa, offering a novel perspective on the cosmetic potential of its microbial associates. A novel agar plate screening platform was used to preliminarily screen the recovered culturable endophytes, followed by a spectrophotometric assay. Extract of one isolate, #4-2AMLGP5-1, exhibited a significant reduction of o-monophenolase and o-diphenolase activity with an IC50 of 123.9 and 139.9 µg/ml, respectively, as compared to 94.5 and 103.6 µg/ml of Kojic acid. The isolate also demonstrated antioxidant potential in DPPH, ABTS, and H2O2 scavenging assays, with IC50 values of 107.5, 87.6, and 115.1 µg/ml, respectively, compared to controls, Quercetin, Trolox, and Ascorbic acid. Multi-locus phylogenetic analysis revealed isolate #4-2AMLGP5-1 as Xylaria psidii, which holds promise as a natural tyrosinase inhibitor with antioxidant properties for future commercial applications.
Indexed as
Identifiers
41642393What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.